Improved immunotherapy with a rapid allergen vaccination schedule: A study of 137 patients

Ear, Nose and Throat Journal

Volumn 82, Issue 11, 2003, Pages 881-887

  Smits, William ^a   Inglefield, Joseph T ^b   Letz, Kevin ^a   Lee, Robert ^c   Craig, Timothy J ^d  

^a Allergy and Asthma Center   (United States)

^b Allergy and Asthma Clinic   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALLERGEN VACCINE; ANTIHISTAMINIC AGENT; AZELASTINE; CETIRIZINE; DIPHENHYDRAMINE; FEXOFENADINE; LORATADINE; PARACETAMOL; PREDNISOLONE; PREDNISONE; SALBUTAMOL; UNCLASSIFIED DRUG; VACCINE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ALLERGIC ASTHMA; ALLERGIC RHINITIS; ALLERGY; ARTICLE; BREATHING DISORDER; CHEST TIGHTNESS; CHILD; CHRONIC SINUSITIS; CLINICAL PROTOCOL; CONTROLLED STUDY; COUGHING; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; NEBULIZATION; PATIENT COMPLIANCE; RASH; SIDE EFFECT; SINUSITIS; STATISTICAL SIGNIFICANCE; THROAT DISEASE; TREATMENT OUTCOME; URTICARIA; VACCINATION; VERTIGO;

EID: 0242637521     PISSN: 01455613     EISSN: None     Source Type: Journal    
DOI: 10.1177/014556130308201116     Document Type: Article

References (32)

1. Creticos PS. Immunotherapy with allergens. JAMA 1992;268: 2834-9.
2. McHugh SM, Lavelle B, Kemeny DM, et al. A placebo-controlled trial of immunotherapy with two extracts of Dermatophagoides pteronyssinus in allergic rhinitis, comparing clinical outcome with changes in antigen-specific IgE, IgG, and IgG subclasses. J Allergy Clin Immunol 1990;86(Pt 1):521-31.
3. Norman PS, Van Metre TE, Jr. The safety of allergenic immunotherapy. J Allergy Clin Immunol 1990;85:522-5.
4. Ross RN, Nelson HS, Finegold I. Effectiveness of specific immunotherapy in the treatment of allergic rhinitis: An analysis of randomized, prospective, single- or double-blind, placebo-controlled studies. Clin Ther 2000;22:342-50.
5. Bousquet J, Michel FB. Specific immunotherapy in asthma: Is it effective? J Allergy Clin Immunol 1994;94:1-11.
6. Cantani A, Businco E, Benincori N, et al. A three year controlled study in children with pollinosis treated with immunotherapy. Ann Allergy 1984;53:79-84.
7. Cantani A, Arcese G, Lucenti P, et al. A three-year prospective study of specific immunotherapy to inhalant allergens: Evidence of safety and efficacy in 300 children with allergic asthma. J Investig Allergol Clin Immunol 1997;7:90-7.
8. Haugaard L, Dahl R, Jacobsen L. A controlled dose-response study of immunotherapy with standardized, partially purified extract of house dust mite: Clinical efficacy and side effects. J Allergy Clin Immunol 1993;91:709-22.
9. Malling HJ. [Allergen-specific immune therapy in the treatment of asthma]. Ugeskr Laeger 2000;162:477-9.
10. Nagata M, Yamamoto H, Tabe K, et al. Effect of rush immunotherapy in house-dust-mite (HDM)-sensitive adult bronchial asthma: Changes in in vivo and in vitro responses to HDM. Intern Med 1993;32:702-9.
11. Ross RN, Nelson HS, Finegold I. Effectiveness of specific immunotherapy in the treatment of asthma: A meta-analysis of prospective, randomized, double-blind, placebo-controlled studies. Clin Ther 2000;22:329-41.
12. Bernstein DI, Mittman RJ, Kagen SL, et al. Clinical and immunologic studies of rapid venom immunotherapy in Hymenoptera-sensitive patients. J Allergy Clin Immunol 1989;84(Pt 1):951-9.
13. Ross RN, Nelson HS, Finegold I. Effectiveness of specific immunotherapy in the treatment of Hymenoptera venom hypersensitivity: A meta-analysis. Clin Ther 2000;22:351-8.
14. Cohn JR, Pizzi A. Determinants of patient compliance with allergen immunotherapy. J Allergy Clin Immunol 1993;91:734-7.
15. Lower T, Henry J, Mandik L, et al. Compliance with allergen immunotherapy. Ann Allergy 1993;70:480-2.
16. Bousquet J, Calvayrac P, Guerin B, et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. I. In vivo and in vitro parameters after a short course of treatment. J Allergy Clin Immunol 1985;76:734-44.
17. Hejjaoui A, Ferrando R, Dhivert, H, et al. Systemic reactions occurring during immunotherapy with standardized pollen extracts. J Allergy Clin Immunol 1992;89:925-33.
18. Bousquet J, Guerin B, Dotte A, et al. Comparison between rush immunotherapy with a standardized allergen and an alum adjuved pyridine extracted material in grass pollen allergy. Clin Allergy 1985;15:179-93.
19. Sundin B, Lilja G, Graff-Lonnevig V, et al. Immunotherapy with partially purified and standardized animal dander extracts. I. Clinical results from a double-blind study on patients with animal dander asthma. J Allergy Clin Immunol 1986;77:478-87.
20. Bousquet J, Hejjaoui A, Dhivert H, et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. Systemic reactions during the rush protocol in patients suffering from asthma. J Allergy Clin Immunol 1989;83:797-802.
21. Hejjaoui A, Dhivert H, Michel FB, Bousquet J. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. IV. Systemic reactions according to the immunotherapy schedule. J Allergy Clin Immunol 1990;85:473-9.
22. Portnoy J, King K, Kanarek H, Homer S. Incidence of systemic reactions during rush immunotherapy. Ann Allergy 1992;68: 493-8.
23. Stewart GE II, Lockey RF. Systemic reactions from allergen immunotherapy. J Allergy Clin Immunol 1992;90(Pt 1):567-78.
24. Sharkey P, Portnoy J. Rush immunotherapy: Experience with a one-day schedule. Ann Allergy Asthma Immunol 1996;76: 175-80.
25. Allergen immunotherapy: Therapeutic vaccines for allergic diseases. Geneva: January 27-9, 1997. Allergy 1998;53(Suppl):1-42.
26. Wynn SR. Immunotherapy compliance - a shot in the dark? Ann Allergy Asthma Immunol 1995;74:195-7.
27. Nielsen L, Johnsen CR, Mosbech H, et al. Antihistamine premedication in specific cluster immunotherapy: A double-blind, placebo-controlled study. J Allergy Clin Immunol 1996;97:1207-13.
28. Portnoy J, Bagstad K, Kanarek H, et al. Premedication reduces the incidence of systemic reactions during inhalant rush immunotherapy with mixtures of allergenic extracts. Ann Allergy 1994; 73:409-18.
29. The waiting period after allergen skin testing and immunotherapy. American Academy of Allergy and Immunology. J Allergy Clin Immunol 1990;85:526-7.
30. Tinkelman D, Smith F, Cole WQ III, Silk HJ. Compliance with an allergen immunotherapy regime. Ann Allergy Asthma Immunol 1995;74:241-6.
31. Weinstein AG. Asthma treatment and noncompliance. Del Med J 2000;72:209-13.
32. Weinstein AG. Clinical management strategies to maintain drug compliance in asthmatic children. Ann Allergy Asthma Immunol 1995;74:304-10.